Context Therapeutics @Context_Tx
Advancing T Cell Engagers for Solid Tumors contexttherapeutics.com Philadelphia, PA Joined May 2018-
Tweets321
-
Followers491
-
Following574
-
Likes97
Today @Context_Tx reported its second quarter 2026 operating and financial results. Read our full press release here: ir.contexttherapeutics.com/news-releases/…
Today, we are pleased to announce positive interim Phase 1 clinical data for our CLDN6 x CD3 T cell engaging bispecific antibody, CTIM-76, in advanced, late-line platinum-resistant ovarian cancer. To learn more, tune in this morning at 8:00 a.m. ET here: bit.ly/4uzN7xM
📣Context announces buyout of CT-202 future milestones and royalties in exchange for a fully paid-up, non-terminable license 🗓️Phase 1 initiation for CT-202 trial expected in third quarter of 2026. $CNTX nasdaq.com/press-release/…
@Context_Tx announces Q1 2026 earnings ⏰ CTIM-76 Ph1a interim data June 2026 ⏰ CT-95 Ph1a interim data Sept 2026 ✅ CT-202 Ph1 initiation Q3 2026 💲Expected runway into mid-2027 $CNTX ir.contexttherapeutics.com/news-releases/…
This morning at #AACR26, colleagues from @Context_Tx will present a poster discussion on CT-202, a Nectin‑4 × CD3 T‑cell engager (TCE). Poster link: First in Human Development of CT-202 — Context Therapeutics
This morning at #AACR26, colleagues from @Context_Tx will present a poster discussion on CT-202, a Nectin‑4 × CD3 T‑cell engager (TCE). CT-202 is Context’s 3rd asset to enter clinical development since 2025. Poster: contexttherapeutics.com/pubs/c202-aacr…
Today @Context_Tx reported its full year 2025 operating and financial results. Our lead program, CTIM-76, is on track to present interim Phase 1a data in June 2026. Read our full press release here: ir.contexttherapeutics.com/news-releases/…
🚨Context Therapeutics ($CNTX) highlights CT-95 and CT-202 programs at #SITC2025 Meeting ✅ Both are potentially best-in-class ✅ Conditional activation at the tumor 👍 Complete tumor resolution in mice 👀View here: Publications — Context Therapeutics globenewswire.com/news-release/2…
🚨 Context Therapeutics $CNTX Q3 2025 Highlights: ✅ CTIM-76 demonstrates encouraging antitumor activity and safety ✅ CT-95 is approaching target dose levels 💰 $76.9M cash and cash equivalents as of Sept 30, 2025 ✅ Expected cash runway into 2027
Context Therapeutics is excited to share that we will be presenting at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting! #SITC2025 #Immunotherapy #TCE ir.contexttherapeutics.com/news-releases/…
Context Therapeutics $CNTX Q2 2025 Highlights: ✅ CTIM-76 & CT-95 Phase 1 dose-escalation trials ongoing ✅ $83.5M cash and cash equivalents as of June 30, 2025 ✅ Expected cash runway into 2027 Read more here: ir.contexttherapeutics.com/news-and-event… #Biotech #Immunotherapy #CancerRes #TCE
$CNTX announces CTIM-76 Trial in Progress poster at #ASCO25 ✅Dosing Cohort 3 of Phase 1 trial ✅ CLDN6 x CD3 TCE for ovarian, endometrial & testicular cancers ✅Initial data expected 1H 2026 📍Poster: June 2, Hall A, 1:30 PM CDT 🔗 contexttherapeutics.com/ctim76 #Biotech
We’re excited to welcome Dr. Karen Chagin as Chief Medical Officer at $CNTX, effective June 9, 2025! With 10+ years leading T cell therapy development at Adaptimmune and Tmunity, she brings deep clinical expertise at a key time for Context. Read more: tinyurl.com/5c78te9f
🚨 Context Therapeutics $CNTX Q1 2025 Highlights: ✅ CTIM-76 & CT-95 in Phase 1 trials ✅ $89.4M cash and cash equivalents as of March 31, 2025 ✅ Expected cash runway into 2027 #Biotech #Immunotherapy #CancerResearch #TCellEngagers Read more here:ir.contexttherapeutics.com/news-releases/…
🚨 We’re excited to welcome Jennifer Dashnau, PhD, MBA as SVP of Technical Operations at Context Therapeutics! Welcome to the team, Jennifer! 👏 #Biotech #Leadership #Immunotherapy #TCellEngagers #ContextTherapeutics #Oncology #WomenInSTEM
The Context team presented preclinical and translational data for CT-95, our mesothelin-targeting T cell engager, at #AACR2025! View the poster here: contexttherapeutics.com/ct95 #Immunotherapy #Biotech $CNTX
📢 Context Therapeutics CEO Martin Lehr will join the T Cell Engagers panel at #AACR25! 🗓 Thursday, April 24 | 🕠 5:45–6:45 PM CT | 📍 Room W192 Moderated by Leerink Partners, the panel includes leaders from J&J, Zymeworks #Biotech #Immunotherapy #TCellEngagers
🚀Another big milestone for $CNTX: First patient dosed in Phase 1 clinical trial of CT-95, our mesothelin x CD3 T cell engaging bispecific antibody targeting solid tumors. CT-95 is Context’s second T cell engaging bispecific antibody to enter the clinic in 2025 💡 #Immunotherapy
Join $CNTX at two premier events! Catch our presentation on Tuesday, April 8 at 10 AM ET during the Stifel Virtual Targeted Oncology Forum, and meet us at the 24th Annual Needham Virtual Healthcare Conference with 1x1 meetings on April 8th #Biotech
Hiran Ravipriya @HRavipriya
56 Followers 378 Following
Jason Knight @JasonKn34316055
46 Followers 211 Following
manflini s @manflini
58 Followers 310 Following
Siti Rahmawati @SitiRah23617570
66 Followers 287 Following
ClarissaWren @Mayfield03572
6 Followers 242 Following Exploring new places and new ideas Sharing kindness wherever I go.
ValdemarViktor kofod-... @olsen99960
1 Followers 51 Following
K.K. @kainukat
0 Followers 99 Following
محمد العتيب... @faedm3
11 Followers 202 Following محللة فنية في الأسواق المالية السعودية والأمريكية📊 تحليل الأسواق واتجاهات الأسهم📈 رؤى مبنية على التحليل الفني💼
Louis Schwenke @louischwenke
15 Followers 14 Following
Prémice Massengo @premicemassengo
0 Followers 12 Following
Jay @buymoremakemore
96 Followers 94 Following Biotech Investor at Border Terrier Capital | MMA Enthusiast | Degrees in Nano Tech and CS | Not Investment Advice
SPREAD LOVE @kle33028
10 Followers 441 Following
Tech4Student @TechForstudent
3 Followers 98 Following
Steve Wagner @SteveWagsInvest
46K Followers 605 Following Investor & Equity Analyst | Blue-chips, Biotech, Special Situations, Micro/Small-Caps | NFA
Jillian Weiss @JL00112233
0 Followers 23 Following
Mary Sphar @sphar12
43 Followers 1K Following
Biotech Nick Sleep @sjsdjjffcvv
0 Followers 2K Following
Rare Diseases @CheckOrphan
18K Followers 5K Following CheckOrphan is the leading #news and information platform dedicated to #rarediseases and #orphandrugs
이재형 @2jaeh_
26 Followers 33 Following
Rich Law @drrichjlaw
5K Followers 2K Following CBO of Haya Therapeutics! (formerly Exscientia/Recursion CBO), PhD computational chemist, MBA, BD, (Oxford, UCSD, LLNL & Evotec), bike racer & LFC fan! #YNWA
投資家(勉強中) @s_investor74
0 Followers 9 Following H30金市場参入/R7.4株式市場参入 目標:学生期間内に株式で$1Mの資産形成 投資元本(JPY):7桁(金属),7桁(株式)
D @D6068681956335
2 Followers 39 Following
Travis Thatcher @207Travis
8 Followers 58 Following
Cruyff12 @Cruyff121
0 Followers 11 Following
Deemo @Deemo17180250
0 Followers 18 Following
Luc @LucLuc47538589
11 Followers 73 Following
Dawn Lundin @lundindaw
1 Followers 53 Following
Tyler Dillon @dillon_tyl8087
1 Followers 4 Following
J @jayabacus
8K Followers 1K Following There isn't a day that goes by that I don't think about the 3 L's from Charlie! Good luck boys!
Karl @Karl1970Karl
64 Followers 134 Following
Mr.West @MrWest8555
214 Followers 1K Following Official Member of the Faithful Black Men Association. The congregation of faithful black men.
Théo Fernandes @TheoFernandes75
10 Followers 562 Following
Francou Lucas @francou_lucas
2 Followers 38 Following
Bob Mccusker @BobMcCuskerX
0 Followers 32 Following
Xohow @Xohow240
22 Followers 530 Following The question isn’t who’s going to let me; it’s who’s going to stop me.
عبدالعزيز س... @azv26
13K Followers 92 Following متداول في السوق الأمريكي أي يسهم أنزله لاتعتبر توصيه LCID $WEKY $AI $LAES أستغفر الله. @azv48
Vertu @Vertu659729
7 Followers 661 Following
Brad Loncar @bradloncar
83K Followers 368 Following #Biotech, Founder of @BiotechTV, KC native, @univmiami hurricane.🧬🙌
Will Meade @thechartdr
274K Followers 0 Following DISCLAIMER: This is not investment advice. I am not a financial advisor. All my posts and tweets are opinions only.
Pharmdca @Pharmdca
109K Followers 177 Following USC Pharmacy Alumni, Full Time Investor. My tweets are a general reflection of my Investments and not a recommendation. Please do your own due diligence.
Adam Feuerstein ✡�... @adamfeuerstein
131K Followers 802 Following Biotech reporter @statnews. Dog ❤️er. Polk Award winner. #COYS. Said one analyst: The likes of Adam Feuerstein attack viciously. On Signal: stataf.54
STAT @statnews
165K Followers 5K Following Reporting from the frontiers of health & medicine. Sign up for any of our newsletters here: https://t.co/CBx3GZBv31
Ripster @ripster47
470K Followers 501 Following Trading & Investing Education Inventor : Ripster Cloud System Founder: Tenet Trade Group https://t.co/0qpaN2fM0W https://t.co/GP2vE0fon3
Bio Stocks™ @BioStocks
72K Followers 92 Following Investor/trader focused primarily in the biopharma sector. Tweets are not investment advice and are not recommendations of any kind.
Daphne Zohar @daphnezohar
27K Followers 799 Following Founder, Board & CEO of @SeaportTX. Co-founder Karuna Tx (now at BMS). previously Founder, Board & CEO PureTech. Cofounder/Executive Producer @BiotechCH.
David Sable @dbsable
9K Followers 1K Following Life sciences, buy side. Ex ob/gyn and IVF doc. Roadie for @priyamayadas Adjunct at @columbia https://t.co/oHce7tNFsQ
Biotech Jim @JamesEKrause
13K Followers 609 Following phd biochem, not ichthyol; prof neurobiol, biotech entrepreneur, neurogeek, inventor, environmentalist focused on sustainability, also ERoEI. #neurosteroids
Izzy @_ms_izzy
58K Followers 747 Following FT Trader - Price & Time Analysis - just my thoughts, not investment advice. “mindset makes money” 10,452 km and not one km less. 🇱🇧
M @bio_clouseau
20K Followers 302 Following Healthcare and Tech investor.bioclouseau at the other site
Vk @biotechinvstr
14K Followers 1K Following Not investment advice.May have position in names mentioned.Opinions expressed strictly my own,not representative of my employer.Factcheck urself.RT≠endorsement
Matthew Phipps @Phipps_MC
845 Followers 817 Following Left behind pipettes and cell culture for spreadsheets and stock tickers
The Pharma Letter @ThePharmaLetter
26K Followers 2K Following Breaking news and analysis for the global pharmaceutical and biotechnology industries
Jeff Cranmer @jeff_cranmer
3K Followers 1K Following Executive Editor, BioCentury; Host, BioCentury This Week podcast. Jersey boy happily ensconced in Cali. Dad. Iggles fan. Cats. @Princeton, @SAISHopkins alum.
Mandy Jackson @ScripMandy
6K Followers 757 Following I am Managing Editor, US Commercial News, for the Citeline Commercial publication Scrip. Views expressed here are strictly my own.
Andrew Dunn @AndrewE_Dunn
12K Followers 2K Following Senior biopharma correspondent at @endpts | Previously @BusinessInsider @BioPharmaDive | [email protected] | Signal (sources only): adunn.68
FirstWord Pharma @fwpharma
55K Followers 595 Following The latest global #pharma news, insights, analysis, and views providing you with an information edge. FirstWord Pharma. Where people who know first, go first.
Lei Lei Wu @leilei_wuu
2K Followers 1K Following reporting on drugs and biotechs @endpts • email me: [email protected] • Signal: leileiwu.24 • ✌️
Amber Tong @AmberTongPW
4K Followers 992 Following Covering China biotech and pharma @business | formerly @endpts | views are my own | say hi: [email protected]
6 Degrees PR @6DegreesPR
274 Followers 419 Following 6 Degrees is a full-service public relations firm that specializes in serving the life sciences industry. Led by principal, @MediaMinder.
Lonza @LonzaGroup
8K Followers 255 Following We are a pioneer in the CDMO industry, setting the pace with cutting-edge science and smart technology to make the medicines of tomorrow.
PharmaVoice @PharmaVoice
35K Followers 2K Following PharmaVoice is the leading community for life sciences leaders to share their stories, voices and ideas. Subscribe at https://t.co/VQzsyqTs0b
BioTuesdays @BioTuesdays
783 Followers 390 Following Giving great healthcare companies and their stories as much exposure as we can. Subscribe to our newsletter. https://t.co/VE9jaNcNac
John George @PHLBizJGeorge
2K Followers 529 Following Health-care and sports business reporter for the Philadelphia Business Journal
pharmaphorum @pharmaphorum
24K Followers 3K Following https://t.co/O0ZJQGuINh, and its digital magazine Deep Dive, is a leading online destination for healthcare and pharmaceutical industry news, insight and debate
BioProcess Online @BioProcessOL
3K Followers 1K Following Your premiere sourcing site for Biopharma and Bioprocess. #upstream #downstream #chromatography #logistics #quality #filtration #singleuse
Proactive USA @proactive_NA
9K Followers 4K Following We lead the world in up-to-the-minute, multi-media news provision. We receive compensation for publishing content here on behalf of our clients. T&Cs apply
headsEts @skaterjrm
841 Followers 6K Following track em #bluebloods #p4 #Horses Racing tweeter. Once a soCal bro (' in Texas now - its not my favorite) APE $AMC STRONG $AEMD
@salem19766 @Salem197662
40 Followers 414 Following
DeepValue @ValueDig
2K Followers 3K Following #Biotech #NGS #Multiomics #Proteomics Long: $TXG $ARWR $SLGL $RPID $TWST $NAUT $BIO $TECH $BRKR $LAB $CYTK $SOPH $WVE $GRAL $ILMN
Boaty McBoatface @srqstockpicker
5K Followers 6K Following Biotech enthusiast and master googler lol Do your own Due Diligence! Personal posts as well. #hbarbarian
HealthcareNinja @HealthcareNinj1
4K Followers 95 Following Investor & engineer. Formerly in pharma and biotech. Passionate about science. Here to offer investing advice and help people learn.
Larry Hsin @xlp007
1K Followers 308 Following Biotech investor, Cell therapy, Gene editing, RNAi and PROTACs
George H Crist, PhD @crist_phd
855 Followers 989 Following Biotech analyst (& in my kids words, a doctor who doesn't help anybody) Tweets are not investment advice, nor should they be considered substitution for your DD
Pickswise @Pickswise
306K Followers 47 Following Your app for FREE picks, props, parlays and all of the can’t-miss sportsbook bonuses. Account run by Intern Alex. 21+. Gambling Problem? Call 1-800-GAMBLER
Tracy Brala @TracyBrala
807 Followers 1K Following 🌈Galvanizing Philly’s Innovation Ecosystem Opinions my own ig:TracyBrala
Edison @Edison_Inv_Res
4K Followers 1K Following Edison is a content-led IR business on a mission to build bigger, better and more engaged investors for our clients.
The Science Advisory ... @ScienceBoard
7K Followers 1K Following The Science Advisory Board is the source for discovery and development in the life sciences.
FdtnForWomensCancer @GYNCancer
5K Followers 1K Following The Foundation for Women's Cancer (FWC) is the leading nat’l provider of info & support for gynecologic cancers. RTs don't = endorse.
Nasdaq Exchange @NasdaqExchange
778K Followers 9K Following Home to the world's most innovative companies. #NasdaqListed
BioBuzz @BioBuzzNetworks
2K Followers 994 Following Get your career buzzin' + access hidden jobs in Biotech | 30k+ community The future of work in life sciences.
LX News @NBCLX
7K Followers 215 Following We have the stories you need with more sass, less suits and a whole lot of subtweets. A nationwide network, watch us live from coast to coast.
Cell&Gene @_CellandGene
358 Followers 18 Following
Jonah Lupton @JonahLupton
554K Followers 3K Following CEO/CIO at @LuptonCapital and @FirstWaveFund, long-biased hedge fund, focused on undervalued growth companies with catalysts that can triple within 2-4 years
Women's Health Innova... @WHICoalition
934 Followers 569 Following A collaborative effort to drive greater research, innovation, and investments in women’s health solutions.
Philadelphia Business... @PHLBizJournal
39K Followers 8K Following The Philadelphia region's source for local business news & events. Part of the American City Business Journals network. Subscribe today! https://t.co/Zmms8lP58i
vlad33301 @vlad33301
1K Followers 58 Following Managing personal biotech portfolio. Maximum 7 different position at any time. Very long term outlook. Hobbyist guitarist. https://t.co/BSDGZyOQLm
Sheff @SheffStation
93K Followers 114 Following Bio Investor, Entrepreneur, Philanthropy, Dad. Insta: Sheffbiotech. Get it Done! Not InvestAdvice! @VIPSheffTrades-https://t.co/jw2hZa7L7S
Canned Salmon Connois... @CloisterRes
5K Followers 703 Following Bacon, not sausage. PhD, but I actually read the papers. In the marketplace of ideas, I see myself as Dollar General.
jenn mcnary @jennmcnary
2K Followers 2K Following fighting DMD and PID to save my sons..lead, follow, or get outta my way! *Disclaimer* I may provide consulting services, my tweets are always my own.
Terri Ellsworth @TerriEllsworth
2K Followers 2K Following Duchenne Advocate/Rare Disease Activist Mom, Designing Mom-Creating awareness & advocating for approval of safe & effective drugs. Words are always my own.
Sasha Damouni Ellis @SashaDamouni
4K Followers 705 Following Founding Partner, Damouni Group. Formerly at Vir Biotech, Marinus Pharma & Bayer. Healthcare Bloomberg reporter in a previous life. Opinions are my own.
Caroline Chen @CarolineYLChen
32K Followers 5K Following Investigative journalist. Not on this platform much any more. Connect on Linkedin or DM for email.
Scott Gottlieb, MD �... @ScottGottliebMD
531K Followers 5K Following Senior Fellow @AEI. Partner @NEA. Contributor @CNBC. 23rd Commissioner of the @US_FDA. Public Boards: @Pfizer @Illumina @TempusAI @UnitedHealthGrp
DRUGS @drug_smolecules
9K Followers 570 Following ☣Femtomolar potency poems and limericks ☣Oceanic Boundlessness (p=0.0001)Trends for United States
You might like
